Company intelligence / Profile preview

Urea Labs

Jersey City, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Urea Labs is a specialized life sciences company focused on the development and commercialization of medical-grade urea formulations for the treatment of hyponatremia. The company's primary product, Urea-Na, is designed to provide a palatable and effective oral treatment option for patients suffering from the Syndrome of Inappropriate Antidiuretic Hormone secretion (SIADH). By leveraging the osmotic diuretic properties of urea, Urea Labs aims to offer a safe alternative to fluid restriction and pharmacological agents like vaptans. The company focuses on improving patient compliance through better-tasting formulations of a long-established therapeutic compound.

Therapeutic areas: Endocrinology
Modalities: Small molecule
Industry: Food & Nutrition

Beyond the preview

Go deeper on Urea Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urea Labs.

Explore the full profile